{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:43:09Z","timestamp":1780630989966,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T00:00:00Z","timestamp":1401926400000},"content-version":"vor","delay-in-days":917,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ejvs.2011.08.016","type":"journal-article","created":{"date-parts":[[2011,10,12]],"date-time":"2011-10-12T13:39:01Z","timestamp":1318426741000},"page":"817-823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Thrombotic Risk Factors and Cardiovascular Events after Endovascular Intervention for Peripheral Arterial Disease"],"prefix":"10.1016","volume":"42","author":[{"given":"M.","family":"Sartori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Favaretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Frascaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Legnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Palareti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2011.08.016_bib1","first-page":"93","article-title":"Consensus document on intermittent claudication from the Central European Vascular Forum 1st edition","volume":"27","author":"Andreozzi","year":"2008","journal-title":"Int Angiol"},{"key":"10.1016\/j.ejvs.2011.08.016_bib2","first-page":"81","article-title":"Inter-society consensus for the management of peripheral arterial disease","volume":"26","author":"Norgren","year":"2007","journal-title":"Int Angiol"},{"key":"10.1016\/j.ejvs.2011.08.016_bib3","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/eurheartj\/ehp553","article-title":"Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease","volume":"31","author":"van Kuijk","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2011.08.016_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1160\/TH08-07-0488","article-title":"Biobanks and the search for predictive biomarkers of local and systemic outcome in atherosclerotic disease","volume":"101","author":"Hurks","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejvs.2011.08.016_bib5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1055\/s-2007-985753","article-title":"Thrombophilia and venous thromboembolism: implications for testing","volume":"33","author":"Cohn","year":"2007","journal-title":"Sem Thromb Haemost"},{"key":"10.1016\/j.ejvs.2011.08.016_bib6","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1160\/TH08-08-0518","article-title":"Peripheral arterial disease and Virchow\u2019s triad","volume":"101","author":"Bennett","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejvs.2011.08.016_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1160\/TH09-11-0772","article-title":"Thrombophilic risk factors and peripheral arterial disease severity","volume":"104","author":"Sartori","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejvs.2011.08.016_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/circ.113.4.463","volume":"113","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2011.08.016_bib9","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adult (Adult Treatment Panel III). Final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2011.08.016_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejvs.2009.02.014","article-title":"G20210A prothrombin mutation and critical limb ischaemia in patients with peripheral arterial disease","volume":"38","author":"Sartori","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2011.08.016_bib11","first-page":"16","article-title":"Prevention Conference V:\u00a0Beyond secondary prevention: identifying the high-risk patient for primary prevention: non-invasive tests of atherosclerosis burden. Writing Group III","volume":"101","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2011.08.016_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1365-2141.2003.04795.x","article-title":"High plasma levels of factor VIII and risk of recurrence of venous thromboembolism","volume":"124","author":"Legnani","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejvs.2011.08.016_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001721-200011010-00005","article-title":"Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study","volume":"11","author":"Smith","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.ejvs.2011.08.016_bib14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9149(03)00537-X","article-title":"Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index","volume":"92","author":"McDermott","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejvs.2011.08.016_bib15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/aje\/kwj051","article-title":"Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis","volume":"163","author":"Tzoulaki","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejvs.2011.08.016_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/152660280100800509","article-title":"Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation","volume":"5","author":"Schillinger","year":"2001","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.ejvs.2011.08.016_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1148\/radiol.2251011809","article-title":"Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis","volume":"225","author":"Schillinger","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.ejvs.2011.08.016_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejvs.2009.05.007","article-title":"Homocysteine and peripheral arterial disease: systematic review and meta-analysis","volume":"38","author":"Khandanpour","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2011.08.016_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jvs.2004.11.015","article-title":"Thrombophilic risk factors for symptomatic peripheral arterial disease","volume":"41","author":"Sofi","year":"2005","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2011.08.016_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0741-5214(91)90020-U","article-title":"The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease","volume":"13","author":"Taylor","year":"1991","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2011.08.016_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0741-5214(99)70345-9","article-title":"Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease","volume":"29","author":"Taylor","year":"1999","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2011.08.016_bib22","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1161\/CIRCULATIONAHA.105.608679","article-title":"Risk factors for progression of peripheral arterial disease in large and small vessels","volume":"113","author":"Aboyans","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2011.08.016_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1583\/03-1086.1","article-title":"Plasma homocysteine and restenosis after femoropopliteal angioplasty","volume":"11","author":"Kovacevic","year":"2004","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.ejvs.2011.08.016_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0021-9150(98)00175-0","article-title":"Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease","volume":"142","author":"Tsakiris","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejvs.2011.08.016_bib25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.ATV.21.5.731","article-title":"Elevated factor VIII levels and the risk of thrombosis","volume":"21","author":"Kamphuisen","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejvs.2011.08.016_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/1358863X07082767","article-title":"Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort","volume":"12","author":"Reich","year":"2007","journal-title":"Vasc Med"},{"key":"10.1016\/j.ejvs.2011.08.016_bib27","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jama.295.9.1050","article-title":"Management of antiphospholipid antibody syndrome: a systematic review","volume":"295","author":"Lim","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ejvs.2011.08.016_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.hoc.2007.10.002","article-title":"The role of antiphospholipid syndrome in cardiovascular disease","volume":"22","author":"Long","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.ejvs.2011.08.016_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1078-5884(05)80131-5","article-title":"Lupus anticoagulant in patients with peripheral vascular disease: a prospective study","volume":"9","author":"Fligelstone","year":"1995","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2011.08.016_bib30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0002-9343(00)00600-8","article-title":"Association between anticardiolipin antibodies and mortality in patients with peripheral arterial disease","volume":"109","author":"Puisieux","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.ejvs.2011.08.016_bib31","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1067\/mva.2001.115163","article-title":"Relationship between antiphospholipid antibodies and progression of lower extremity arterial occlusive disease after lower extremity bypass operations","volume":"33","author":"Lam","year":"2001","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2011.08.016_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0021-9150(01)00759-6","article-title":"Arterial wall thickness and the risk of recurrent ischemic events in carriers of the prothrombin G20210A mutation with clinical manifestations of atherosclerosis","volume":"163","author":"Gerdes","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejvs.2011.08.016_bib33","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/ATVBAHA.108.179739","article-title":"Concept of vulnerable\/unstable plaque","volume":"30","author":"Finn","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejvs.2011.08.016_bib34","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.ATV.15.9.1512","article-title":"A\u00a0definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis","volume":"15","author":"Stary","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588411005673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588411005673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:50:43Z","timestamp":1761043843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588411005673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1078588411005673"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2011.08.016","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic Risk Factors and Cardiovascular Events after Endovascular Intervention for Peripheral Arterial Disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2011.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}